Vines Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Vines Capital Management's LLY Position: Q2 2026 in Review
Vines Capital Management increased its Eli Lilly (LLY) stake by 10% in Q2 2026, buying an estimated $46K and bringing the position to 495 shares worth $594K. The position accounts for 0.49% of the portfolio, ranked #39.
Vines Capital Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Vines Capital Management held 495 shares of Eli Lilly worth $594K as of Q2 2026.
- Vines Capital Management bought 45 Eli Lilly shares in Q2 2026, an estimated $46K.
- Eli Lilly made up 0.49% of Vines Capital Management's portfolio in Q2 2026, its #39 holding.
- Vines Capital Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
- 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Vines Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.